PortfoliosLab logoPortfoliosLab logo
GENI vs. AGX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GENI vs. AGX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Genius Sports Limited (GENI) and Argan, Inc. (AGX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GENI achieves a -46.82% return, which is significantly lower than AGX's 135.64% return.


GENI

1D
-1.35%
1M
9.53%
YTD
-46.82%
6M
-45.84%
1Y
-39.77%
3Y*
-0.06%
5Y*
-20.89%
10Y*

AGX

1D
-6.74%
1M
12.25%
YTD
135.64%
6M
121.56%
1Y
255.33%
3Y*
170.89%
5Y*
75.91%
10Y*
37.51%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GENI vs. AGX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
GENI
Genius Sports Limited
-46.82%27.40%39.97%73.11%-53.03%-53.94%
AGX
Argan, Inc.
135.64%130.61%198.31%30.24%-2.01%-26.19%

Correlation

The correlation between GENI and AGX is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Apr 21, 2021

0.16

Fundamentals

Market Cap

GENI:

$1.58B

AGX:

$10.46B

EPS

GENI:

-$0.61

AGX:

$11.38

PS Ratio

GENI:

2.14

AGX:

10.02

PB Ratio

GENI:

2.27

AGX:

22.09

Total Revenue (TTM)

GENI:

$713.45M

AGX:

$1.04B

Gross Profit (TTM)

GENI:

$161.30M

AGX:

$217.93M

EBITDA (TTM)

GENI:

-$70.25M

AGX:

$163.99M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GENI vs. AGX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GENI
GENI Risk / Return Rank: 1919
Overall Rank
GENI Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
GENI Sortino Ratio Rank: 1818
Sortino Ratio Rank
GENI Omega Ratio Rank: 1818
Omega Ratio Rank
GENI Calmar Ratio Rank: 2222
Calmar Ratio Rank
GENI Martin Ratio Rank: 2121
Martin Ratio Rank

AGX
AGX Risk / Return Rank: 9696
Overall Rank
AGX Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
AGX Sortino Ratio Rank: 9494
Sortino Ratio Rank
AGX Omega Ratio Rank: 9292
Omega Ratio Rank
AGX Calmar Ratio Rank: 9898
Calmar Ratio Rank
AGX Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GENI vs. AGX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Genius Sports Limited (GENI) and Argan, Inc. (AGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GENIAGXDifference
Sharpe ratioReturn per unit of total volatility

-4.05

Sortino ratioReturn per unit of downside risk

-4.36

Omega ratioGain probability vs. loss probability

0.92

1.47

-0.55

Calmar ratioReturn relative to maximum drawdown

-0.56

10.30

-10.86

Martin ratioReturn relative to average drawdown

-0.99

29.33

-30.32

GENI vs. AGX - Sharpe Ratio Comparison

The current GENI Sharpe Ratio is -0.61, which is lower than the AGX Sharpe Ratio of 3.43. The chart below compares the historical Sharpe Ratios of GENI and AGX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GENI vs. AGX - Drawdown Comparison

The maximum GENI drawdown since its inception was -90.97%, roughly equal to the maximum AGX drawdown of -94.37%. Use the drawdown chart below to compare losses from any high point for GENI and AGX.


Loading charts...

Drawdown Indicators


GENIAGXDifference

Max Drawdown

Largest peak-to-trough decline

-90.97%

-94.37%

+3.40%

Max Drawdown (1Y)

Largest decline over 1 year

-71.07%

-24.96%

-46.11%

Max Drawdown (3Y)

Largest decline over 3 years

-71.07%

-43.75%

-27.32%

Max Drawdown (5Y)

Largest decline over 5 years

-89.95%

-43.75%

-46.20%

Max Drawdown (10Y)

Largest decline over 10 years

-54.61%

Current Drawdown

Current decline from peak

-76.49%

-6.74%

-69.75%

Average Drawdown

Average peak-to-trough decline

-67.23%

-48.30%

-18.93%

Ulcer Index

Depth and duration of drawdowns from previous peaks

40.12%

8.75%

+31.37%

Volatility

GENI vs. AGX - Volatility Comparison

Genius Sports Limited (GENI) has a higher volatility of 22.01% compared to Argan, Inc. (AGX) at 20.17%. This indicates that GENI's price experiences larger fluctuations and is considered to be riskier than AGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GENIAGXDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.01%

20.17%

+1.84%

Volatility (6M)

Calculated over the trailing 6-month period

57.35%

54.86%

+2.49%

Volatility (1Y)

Calculated over the trailing 1-year period

64.95%

74.89%

-9.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

67.17%

51.29%

+15.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

67.84%

46.04%

+21.80%

Dividends

GENI vs. AGX - Dividend Comparison

GENI has not paid dividends to shareholders, while AGX's dividend yield for the trailing twelve months is around 0.25%.


PositionTTM20252024202320222021202020192018201720162015
AGX
Argan, Inc.
0.25%0.52%0.93%2.24%2.71%1.94%7.31%2.49%1.98%4.44%1.42%2.16%
GENI
Genius Sports Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

GENI vs. AGX - Financials Comparison

This section allows you to compare key financial metrics between Genius Sports Limited and Argan, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


50.00M100.00M150.00M200.00M250.00M300.00M20222023202420252026
187.95M
290.95M
(GENI) Total Revenue
(AGX) Total Revenue
Values in USD except per share items

GENI vs. AGX - Profitability Comparison

The chart below illustrates the profitability comparison between Genius Sports Limited and Argan, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-30.0%-20.0%-10.0%0.0%10.0%20.0%30.0%20222023202420252026
22.9%
21.0%
Portfolio components
GENI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Genius Sports Limited reported a gross profit of 42.99M and revenue of 187.95M. Therefore, the gross margin over that period was 22.9%.

AGX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported a gross profit of 61.11M and revenue of 290.95M. Therefore, the gross margin over that period was 21.0%.

GENI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Genius Sports Limited reported an operating income of -29.63M and revenue of 187.95M, resulting in an operating margin of -15.8%.

AGX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported an operating income of 45.40M and revenue of 290.95M, resulting in an operating margin of 15.6%.

GENI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Genius Sports Limited reported a net income of -55.47M and revenue of 187.95M, resulting in a net margin of -29.5%.

AGX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported a net income of 46.06M and revenue of 290.95M, resulting in a net margin of 15.8%.


Frequently Asked Questions


GENI and AGX have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GENI has higher volatility (22.01%) compared to AGX (20.17%). In terms of maximum drawdown, GENI dropped -90.97% vs AGX's -94.37%.

AGX currently has the higher Sharpe Ratio (3.43 vs -0.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GENI and AGX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer